FR940504-2-00080 FR940504-2-00070 Manufacturer of Controlled Substances; Registration By Notice dated March 3, 1994, and published in the Federal Register on March 11, 1994 (59 FR 11625), Sanofi Winthrop LP, DBA Sterling Organics, 33 Riverside Avenue, Rensselaer, New York 12144, made application to the Drug Enforcement Administration to be registered as a bulk manufacturer of Meperidine (9230), a basic class of controlled substance listed in Schedule II. No comments or objections have been received. Therefore, pursuant to section 303 of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and Title 21, Code of Federal Regulations, ยง1301.54(e), the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic class of controlled substance listed above is granted. Dated: April 25, 1994. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 94&hyph;10682 Filed 5&hyph;3&hyph;94; 8:45 am] BILLING CODE 4410&hyph;09&hyph;M
